Replies to post #213243 on Biotech Values

[DewDiligence]

COCP still trying to develop a better HCV drug:

https://globenewswire.com/news-release/2018/04/03/1459114/0/en/Cocrystal-Pharma-Receives-FDA-Clearance-to-Initiate-Phase-2a-Clinical-Study-Evaluating-CC-31244-for-the-Treatment-of-Hepatitis-C-Virus.html

Good luck with that!

[DewDiligence]

Microcap COCP still seeking 6wk HCV regimen:

https://finance.yahoo.com/news/cocrystal-pharma-commences-enrollment-initiates-113500375.html

In this single-arm phase-2 trial, patients will get 2 weeks of COCP’s non-nuke, CC-31244 with GILD’s SOF/VEL, then 4 weeks of SOF/VEL alone. COCP does not have a collaborative agreement with GILD, as far as I know.